Tobacco harm reduction is, at its heart, a justice issue.
Yet when it comes to nicotine and safer alternatives to smoking, that arc is bending in a strange direction.
“Of all the forms of inequality, injustice in health is the most shocking and inhumane.” Martin Luther King Jr. was talking about the way systems fail people long before they get sick. Public health, at its best, is supposed to be the tool that levels the playing field, that “bends the arc” towards equity and justice, not away from it.
The forgotten voice: people who actually smoke
You would not know it from many headlines, but tobacco harm reduction starts with a simple, uncomfortable truth: millions of people who smoke either cannot quit or are not ready to, even after doing everything they were told to do. They tried to “just stop.” They tried willpower, patches, gum, prescriptions. Some succeeded; many did not.
When these people pick up a vape, or switch to another non‑combustible nicotine product and finally stop smoking, they are not making a theoretical choice. They are making a practical one. They notice they can walk up the stairs without wheezing. Their smoker’s cough eases. Food tastes better again. Their families notice the difference.
But in much of our public conversation, their experience does not just get ignored; it gets erased. Instead of being seen as people who have taken a big step away from a product that kills half its long‑term users, they are often treated as if they have merely swapped one vice for another, or worse, as dupes of “Big Tobacco.”
The reality of their lives rarely fits neatly into a slogan.
Misunderstanding nicotine – on purpose
A big part of this misalignment comes from a stubborn, and sometimes deliberate, confusion between smoking and nicotine.
Smoking is deadly largely because burning tobacco creates toxic smoke loaded with chemicals that damage lungs, blood vessels, and organs over time. Nicotine is the drug that keeps people coming back, but it is not the main cause of the cancers and heart disease that make smoking so lethal. That is why nicotine patches and gum have been approved and used for decades in medicine.
Yet in public debate, nicotine and smoking are often treated as identical evils. If a product contains nicotine, it is reflexively condemned, even when it removes the smoke and drastically cuts exposure to the toxic by‑products of burning tobacco. This blurring of lines does not happen by accident. It is politically convenient. It allows critics to dismiss harm reduction entirely: if all nicotine is “as bad as” smoking, then there is no point in talking about safer options.
For the person who has finally managed to get off cigarettes by switching to a vape or another smoke‑free product, being told they have made “no progress” is not just insulting. It is false.
When anti‑industry sentiment overwhelms evidence
None of this is to deny the long, well‑documented history of cigarette companies deceiving the public about the harms of smoking. That history is real, and it understandably shapes how people view any product that involves tobacco or nicotine.
But that history has also hardened into a kind of reflex: if a technology involves nicotine and a company with a tobacco connection has any role, it must be a trick. Harm reduction becomes “just another marketing scam.”
Any study showing lower risk is presumed tainted. Any consumer who says they feel better is written off as manipulated.
This is not evidence‑based thinking; it is guilt by association.
There is a difference between trusting industry claims and acknowledging independent evidence that some products are dramatically less harmful than cigarettes. There is a difference between demanding strong regulation and trying to ban, tax, or scare safer options out of existence because they offend a particular moral or political view.
When public policy is driven primarily by the urge to punish “Big Tobacco,” rather than to reduce the number of people dying from smoking, the people who pay the price are not the executives. They are ordinary smokers, often on low incomes, in marginalised communities, who have fewer choices and less access to healthcare.
Whose health are we protecting?
If we step back and ask, “Whose health is public health protecting here?” the contradictions become hard to ignore.
On paper, we say the goal is to reduce disease and death from smoking. In practice, many campaigns spend more time attacking the existence of safer nicotine products than they do tackling the continued sale of cigarettes. We tolerate the product that we know kills, while waging war on products that, even with uncertainties, are clearly much less harmful than burning tobacco.
This is not what justice in health should look like.
For a person at the sharp end of these decisions, the message is clear: your lived experience does not matter. Your progress away from cigarettes does not count. Your reduction in harm is invisible because it does not fit a preferred narrative about drugs, addiction, and corporate villains.
Bending the arc back to people
Public health can, and should, be better than this.
We can be honest about the risks of all nicotine products and still respect the simple fact that getting away from smoke is a huge health win. We can hold the tobacco industry to account and still support people who use safer products to escape cigarettes. We can prioritise the voices of those who have left smoking behind over the comfort of tidy, abstinence‑only slogans.
If injustice in health is the most shocking and inhumane inequality, then denying people a realistic pathway away from the most dangerous form of nicotine use because it offends our ideology is, in fact, a modern form of that injustice.
At a minimum, we owe people who smoke and/or use nicotine the respect of listening to their experiences and aligning our policies with what the best evidence and their lives are both telling us: for many, harm reduction is not a loophole. It is their lifeline.